Why is Carlyle stock sliding today?

Carlyle Group (CG) stock fell 0.8% to $41.99 in pre-market trading after UBS downgraded it to Neutral, cutting its price target to $47 from $60. UBS cited reduced confidence in Carlyle's growth trajectory and ability to meet 2028 financial targets. Other analysts have also lowered price targets. The stock is below its 52-week high of $67.30 but above its low of $35.41.

Original reporting
Published Nov 10, 2026, 12:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$CG
Bearish
high confidence
Mentioned
$CG
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CGBearishHigh
01

Why it matters

The UBS downgrade is the primary catalyst for today's price slide, reinforcing concerns about fee‑related earnings growth.

02

Market read

CG's pre‑market decline reflects immediate market reaction to a fresh downgrade, offering a short‑term trading opportunity.

03

What to watch

Carlyle's recent fundraising ambition and strong earnings beat may cushion longer‑term performance despite the downgrade.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Carlyle Group reported Q3 2026 earnings that beat estimates but left investors wary of near‑term growth, prompting analyst target revisions.

Company-level read

Ticker impact

$CGBearishHigh confidence
Context

UBS downgraded Carlyle Group to Neutral and cut its price target, causing the stock to slip 0.8% in pre‑market trading.

Expected impact

likely downward pressure as investors price in the lower target and reduced growth outlook

Evidence & confidence

UBS is a major sell‑side analyst; its target cut and rating downgrade are new and directly linked to the observed pre‑market price decline.

Market effects

Alternative‑asset managers may see heightened scrutiny on fee growth expectations.

U.S. equity markets could see modest drag in the financial sector as the downgrade spreads.

Limited; the impact is primarily on U.S. listed alternative‑asset firms.

Counterpoint

If investors view the downgrade as over‑reacted, CG could rebound on short‑term buying interest.

Key entities

  • Carlyle Group

    Alternative asset manager listed on NYSE under ticker CG.

  • UBS

    Downgraded CG to Neutral and cut price target to $47.

Related articles

$CGHigh

UBS downgrades Carlyle Group stock rating on growth concerns

UBS downgraded Carlyle Group (CG) from Buy to Neutral, lowering its price target to $47. Analysts cited concerns about growth and reduced fee-related earnings forecasts. The stock is down 26.9% year-to-date, trading at $42.31. UBS also lowered its 2027 and 2028 earnings estimates. Carlyle's Q3 2026 results beat expectations but the stock declined due to growth outlook uncertainties.

$CGMed

Carlyle Group Targets First Buyout Fund Close as $200 Billion Fundraising Push Takes Shape

Carlyle Group (CG) aims to close its first buyout fund as part of a $200 billion fundraising initiative. The company announced its first defense fund deal, Secturion, and highlighted a $5 billion structured transaction via AlpInvest. Carlyle expects growth in credit secondaries and fee-related earnings, with a focus on private equity products. The firm is also restructuring its European buyout team, with the next fund expected to be smaller than its predecessor.

$CGMed

Carlyle and EBRD Agree Sale

Carlyle (CG) and EBRD agreed to sell Black Sea Oil & Gas (BSOG), Romania's largest offshore gas producer, to Mazarine Energy. The deal, pending approval, transfers ownership of BSOG, which supplies 12% of Romania's gas demand, to Mazarine. Carlyle invested over $400M in BSOG's Midia Gas Development project. BSOG will remain the operator, ensuring continuity.

$CGHighAI 8/10

Carlyle 3Q 2026: Revenue $334.1M, EPS ($0.02) — 10-Q Summary

Carlyle reported Q3 2026 revenue of $334.1M, a slight YoY decrease, and a net loss of $0.02 per share. Fund management fees and performance allocations declined, while principal investment income and compensation expenses fell. Distributable earnings rose to $432.5M, with $11.0B deployed and $10.8B in inflows. AUM totaled $478.5B.